AbbVie(ABBV)
Focus: AbbVie is a $54.3B revenue pharmaceutical giant with 50,000 employees, specializing in small molecules and biologics across immunology, oncology, neuroscience, aesthetics, and eye care. It maintains a leading position in immunology and oncology with a diversified portfolio generating substantial Part D spending.
Profile data last refreshed 16h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Employees
50,000
Open Jobs
0
2 recent layoff filings (12 mo) — 87 affected
- 5/19/2026 — CA · 85 affected · Layoff Amendment
- 11/10/2025 — 4410 Rosewood Drive Pleasonton CA 94588, CA · 2 affected · Closure
Source: state DOL filings via Big Local News
About AbbVie
AI assessmentNot HiringNo open roles listed right now. Follow AbbVie to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from AbbVie's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
6/9 — Partial
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
7 imminent
ACULAR LS
Hiring
Stable
Revenue
$54.3B
FY2025
Key Products
$2.4B Part DStable
Peak8.5yr
Anchor franchise generating 19% of company revenue; remains at peak lifecycle with 9+ years of exclusivity remaining.
Help build intelligence for AbbVie
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.